JHS Svendgaard Laboratories Limited is an India-based private label manufacturer of oral care products. The Company is engaged in manufacturing a range of oral and dental products for national and international brands. The Company is involved in the manufacturing and exporting of oral care and hygiene products, including toothbrushes, toothpastes, mouthwash, sanitizers and job work of detergent powder. Its domestic market products include toothbrushes, toothpaste, mouthwash, laundry sanitizer, and room fresheners. Its international market products include toothbrush, toothpaste and denture tablet. The Companyâ€™s subsidiary is JHS Svendgaard Mechanical and Warehouse Private Limited.

Employees

263

Sector

Personal Products

More about the company

Quotes

Date	Price	Change	Volume
31/07/26	₹7.570	+3.98%	285,789
30/07/26	₹7.280	-2.54%	402,028
29/07/26	₹7.470	-1.32%	39,814
28/07/26	₹7.570	+2.30%	27,440
27/07/26	₹7.400	-1.20%	57,649

Delayed Quote NSE India S.E.

More quotes

Income Statement and Estimates

More financial data

Market Closed - NSE India S.E. Other stock markets 14:05:08 31/07/2026 +03			5-day change	1st Jan Change
7.570 ^INR	+3.98%		+1.07%	-22.91%

05-26	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-10	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Market Cap	573M 6M 5.21M 4.85M 4.46M 8.41M 8.54M 57.2M 22.45M 285M 22.52M 22.03M 956M	P/E 2024	-8.19x	P/E 2025	-4.71x
Enterprise Value	452M 4.73M 4.12M 3.83M 3.52M 6.64M 6.74M 45.15M 17.72M 225M 17.78M 17.39M 754M	EV / Sales 2024	1.67x	EV / Sales 2025	0.91x
Free-Float	49.01%	Yield 2024 *	-	Yield 2025	-

05-26	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-10	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-14	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
13/08/25	JHS Svendgaard Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
01/07/25	JHS Svendgaard Laboratories Limited Announces Cessation of Mukul Pathak as Independent Director, Effective July 01, 2025	CI
05/03/25	JHS Svendgaard Laboratories Approves Investment Of 50 Mln Rupees In JHS Svendgaard Retail Ventures	RE
05/03/25	JHS Svendgaard Retail Ventures Limited announced that it expects to receive funding from JHS Svendgaard Laboratories Limited, KSS Growth LLP	CI
13/02/25	JHS Svendgaard Laboratories Limited Appoints Paramvir Singh as A Director	CI
11/02/25	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
13/11/24	JHS Svendgaard Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
12/08/24	JHS Svendgaard Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
07/08/24	JHS Svendgaard Laboratories Raises INR300 Million via Preferential Issue	MT
03/08/24	JHS Svendgaard Laboratories Limited announced that it has received INR 224.9999 million in funding from COEUS Global Opportunities Fund, M.B. Finmart Private Limited, Milky Investment And Trading Company, Puran Associates Pvt. Ltd., Vic Enterprises Private Limited and another investor	CI

1 day	+3.98%
1 week	+1.07%
1 month	+1.47%
3 months	-14.46%
6 months	-27.77%
Current year	-22.91%

JHS Svendgaard Laboratories Limited Stock

Stocks

JHS

INE544H01014

Personal Products

Valuation: JHS Svendgaard Laboratories Limited

Chart: JHS Svendgaard Laboratories Limited

Latest news : JHS Svendgaard Laboratories Limited

Press Releases: JHS Svendgaard Laboratories Limited

Quotes and Performance

Course Extremes

Managers and Directors: JHS Svendgaard Laboratories Limited

Sanitary Products

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	7.27	8.16
1 month	7	8.16
Current year	6.26	12.9
1 year	6.26	13.9
3 years	6.26	39.5
5 years	6.26	39.5
10 years	6.26	82.85

Manager	Title	Age	Since
Paramvir Singh Pabla CEO	Chief Executive Officer	47	30/06/2010
Ashish Goel DFI	Director of Finance/CFO	40	06/04/2009
Komal Jhawar CMP	Compliance Officer	-	10/11/2022

Director	Title	Age	Since
Nikhil Nanda BRD	Director/Board Member	53	08/10/2004
Paramvir Singh Pabla BRD	Director/Board Member	47	13/11/2024
Rajagopal C. Venkateish CHM	Chairman	67	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JHS SVENDGAARD LABORATORIES LIMITED	+3.98%	+1.07%	-40.11%	-63.61%	6.67M
KIMBERLY-CLARK CORPORATION	-0.80%	-0.36%	-12.29%	-15.33%	36.58B
UNICHARM CORPORATION	-2.38%	+5.15%	-3.78%	-42.67%	11.12B
HENGAN INTERNATIONAL GROUP COMPANY LIMITED	-4.33%	+6.82%	+5.36%	-22.75%	3.81B
SOFTCARE LIMITED	-1.50%	+4.61%	-	-	2.73B
GILLETTE INDIA LIMITED	-1.15%	-2.52%	-29.81%	+34.79%	2.63B
OIL-DRI CORPORATION OF AMERICA	+1.18%	+0.43%	+75.90%	+216.11%	1.42B
C&S PAPER CO.,LTD	-0.40%	+7.33%	-1.32%	-32.58%	1.42B
CHONGQING BAIYA SANITARY PRODUCTS CO., LTD.	-0.61%	+10.36%	-42.47%	-8.07%	940M
DENCARE (CHONGQING) ORAL CARE CO., LTD.	-0.41%	+10.99%	-30.16%	-13.36%	810M
Average	-0.64%	+4.11%	-8.74%	+5.84%	6.15B
Weighted average by Cap.	-1.29%	+2.57%	-8.65%	-13.42%

	2024	2025
Net sales	729M 7.64M 6.64M 6.18M 5.67M 10.71M 10.88M 72.83M 28.58M 363M 28.68M 28.05M 1.22B	923M 9.67M 8.4M 7.82M 7.18M 13.56M 13.77M 92.21M 36.19M 459M 36.31M 35.51M 1.54B
Net income	-155M -1.62M -1.41M -1.31M -1.2M -2.27M -2.31M -15.45M -6.06M -76.99M -6.08M -5.95M -258M	-197M -2.07M -1.8M -1.67M -1.54M -2.9M -2.95M -19.73M -7.74M -98.3M -7.77M -7.6M -330M
Net Debt	-50.11M -525K -456K -425K -390K -736K -748K -5.01M -1.96M -24.95M -1.97M -1.93M -83.65M	-121M -1.26M -1.1M -1.02M -938K -1.77M -1.8M -12.05M -4.73M -60.02M -4.74M -4.64M -201M